Latest Pear Tree Pharmaceuticals News
May 21, 2018
Dare acquiring Pear Tree PDF Daré BioScience Inc. (NASDAQ:DARE) will acquire Pear Tree Pharmaceuticals Inc. (Cambridge, Mass. ), gaining its PT-101. The vaginal formulation of tamoxifen... Read the full 78 word article User Sign in Individual Use $30.00 USD What is BioCentury? BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.